United Kingdom · Question · Written question
UIN 72255
Voluntary Scheme for Branded Medicines Pricing and Access
Original
Introduced
26 October 2022
Last action
3 November 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
3 November 2022
Summary
To ask the Secretary of State for Health and Social Care, what (a) meetings and (b) discussions he has with representatives of (i) pharmaceutical and (ii) life science companies on changes to the Voluntary Scheme for Branded Medicines Pricing and Access (
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
26 October 2022
Written question
To ask the Secretary of State for Health and Social Care, what (a) meetings and (b) discussions he has with representatives of (i) pharmaceutical and (ii) life science companies on changes to the Voluntary Scheme for Branded Medicines Pricing and Access (
Source: Commons
3 November 2022
Answer
Ministerial meetings are published on GOV.UK at the following link: https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022 No specific assessment of the potential impact of changes to the Voluntary Scheme...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-10-26/72255
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1536554
- uk · wq-1536554 · source updated 3 November 2022